The United States of America, as Represented by the Secretary, Department of Health and Human Services;Baylor College of Medicine;The United States of America; as Represented by the Secretary; Department of Health and Human Services
发明人:
Tweardy, David J.,Kasembeli, Moses M.,Xu, Marvin X.,Milner, Josh,Bocchini, Claire E.
申请号：
AU2014290367
公开号：
AU2014290367A1
申请日:
2014.07.18
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
Embodiments of the invention include methods of preventing and/or reducing the risk or severity of an allergic reaction in an individual. In some embodiments, particular small molecules are employed for prevention and/or reduction in the risk or severity of anaphylaxis. In at least particular cases, the small molecules are inhibitors of STAT3. In some cases, the small molecule comprises N-(1',2-dihydroxy-1,2'-binaphthalen-4'-yl)-4-methoxybenzenesulfonamide.
